BMRN– BioMarin Pharmaceutical Inc evelops and commercializes pharmaceuticals for various diseases and medical conditions.
|
BMRN– BioMarin Pharmaceutical Inc |
||
| Fundamentals | Previously closed at | 89.65 |
| Day’s high | 91.26 | |
| Day’s low | 88.94 | |
| P/E ratio | NA | |
| EPS | -1.18 | |
| Analysts opinion | BioMarin is a specialist in rare-disease specialist. The controversial drug Kyndrisa, which intended to treat Duchenne muscular dystrophy was rejected by the Committee for Medical Products for Human Use (CHMP). Analyst confidence meter, a proprietary algorithm of Stockal gives 89% buy based on analyst ratings. |
| Sentiments | The sentiment index is 50% positive according to Stockal proprietary algorithm. |
| NA Media Pulse | The stock has 64% higher social media chatter than usual. |
CRM – Salesforce.com Inc is a provider of enterprise cloud computing solutions, with a focus on customer relationship management.
|
CRM – Salesforce.com Inc |
||
| Fundamentals | Previously closed at | 83.71 |
| Day’s high | 84.06 | |
| Day’s low | 83.16 | |
| P/E ratio | NA | |
| EPS | -0.02 | |
| Analyst opinion | Salesforce announced that it would buy e-commerce specialist Demandware in a $2.8 Billion deal. Salesforce President Keith Block said that the new E-commerce cloud will join Salesforce’s existing Sales, Marketing, Service and the upcoming IoT clouds. Confidence Meter reads a 75% buy. This a proprietary algorithm of Stockal tracks Analyst confidence in the Stock. |
| Sentiments | The sentiment index is 100% positive on Stockal proprietary algorithm. |
| Social Media Pulse | The stock has 54% higher social chatter than usual. |
Disclaimer: This blog contains an aggregated view of analysts and opinions by the author. Do not consider this as financial advice. See http://stockal.com/legalities/
